Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.

This article discusses a study conducted in China that examined the combined effects of lipoprotein(a) (Lp(a)) and high-sensitivity C-reactive protein (Hs-CRP) on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction (AMI). The study found that elevated levels of both Lp(a) and Hs-CRP significantly increased the risk of cardiovascular death in AMI patients. The study emphasizes the importance of considering the combined effects of these biomarkers in managing AMI patients. Additionally, the article provides references to other scientific studies that explore the relationship between Lp(a), CRP, and cardiovascular risk in different patient populations. [Extracted from the article]